HEADER TRANSLATION 22-FEB-12 4DUM TITLE CO-CRYSTAL STRUCTURE OF EIF4E WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EIF-4E, EIF4E, EIF-4F 25 KDA SUBUNIT, MRNA CAP-BINDING COMPND 5 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EIF4E, EIF4EL1, EIF4F; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET101 KEYWDS CAP-BINDING PROTEIN, TRANSLATION INITIATION FACTOR, M7GTP, KEYWDS 2 TRANSLATION EXPDTA X-RAY DIFFRACTION AUTHOR X.MIN,S.JOHNSTONE,N.WALKER,Z.WANG REVDAT 4 28-FEB-24 4DUM 1 REMARK SEQADV REVDAT 3 27-JUN-12 4DUM 1 JRNL REVDAT 2 02-MAY-12 4DUM 1 JRNL REVDAT 1 11-APR-12 4DUM 0 JRNL AUTH X.CHEN,D.J.KOPECKY,J.MIHALIC,S.JEFFRIES,X.MIN,J.HEATH, JRNL AUTH 2 J.DEIGNAN,S.LAI,Z.FU,C.GUIMARAES,S.SHEN,S.LI,S.JOHNSTONE, JRNL AUTH 3 S.THIBAULT,H.XU,M.CARDOZO,W.SHEN,N.WALKER,F.KAYSER,Z.WANG JRNL TITL STRUCTURE-GUIDED DESIGN, SYNTHESIS, AND EVALUATION OF JRNL TITL 2 GUANINE-DERIVED INHIBITORS OF THE EIF4E MRNA-CAP JRNL TITL 3 INTERACTION. JRNL REF J.MED.CHEM. V. 55 3837 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22458568 JRNL DOI 10.1021/JM300037X REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 5969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 292 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 401 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 19 REMARK 3 BIN FREE R VALUE : 0.4010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.08000 REMARK 3 B22 (A**2) : 1.51000 REMARK 3 B33 (A**2) : -1.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.425 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.317 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.910 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.852 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1641 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2222 ; 1.506 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 189 ; 6.718 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 84 ;38.487 ;23.929 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 284 ;19.904 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;19.663 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 228 ; 0.100 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1255 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 935 ; 0.818 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1512 ; 1.581 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 706 ; 1.835 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 708 ; 3.215 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4DUM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000070802. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : RIGAKU VARIMAX HR OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6282 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 62.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PURIFIED PROTEIN WHICH CONTAINED REMARK 280 100 UM M7-GTP WAS THEN CONCENTRATED TO ABOUT 7 MG/ML IN 20 MM REMARK 280 HEPES, PH7.6, 100 MM KCL, 1MM DTT, 0.1 MM EDTA FOR REMARK 280 CRYSTALLIZATION. THE M7-GTP-BOUND EIF4E PROTEIN WAS CRYSTALLIZED REMARK 280 WITH 1:1 RATIO OF PROTEIN SOLUTION TO RESERVOIR SOLUTION OF 17- REMARK 280 20% PEG-3350 AND 0.1-0.4M NA FORMATE, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.11250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.72100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.38300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.72100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.11250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.38300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 ASP A -21 REMARK 465 TYR A -20 REMARK 465 LYS A -19 REMARK 465 ASP A -18 REMARK 465 ASP A -17 REMARK 465 ASP A -16 REMARK 465 ASP A -15 REMARK 465 LYS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 THR A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 THR A 3 REMARK 465 VAL A 4 REMARK 465 GLU A 5 REMARK 465 PRO A 6 REMARK 465 GLU A 7 REMARK 465 THR A 8 REMARK 465 THR A 9 REMARK 465 PRO A 10 REMARK 465 THR A 11 REMARK 465 PRO A 12 REMARK 465 ASN A 13 REMARK 465 PRO A 14 REMARK 465 PRO A 15 REMARK 465 THR A 16 REMARK 465 THR A 17 REMARK 465 GLU A 18 REMARK 465 GLU A 19 REMARK 465 GLU A 20 REMARK 465 LYS A 21 REMARK 465 THR A 22 REMARK 465 GLU A 23 REMARK 465 SER A 24 REMARK 465 ASN A 25 REMARK 465 GLN A 26 REMARK 465 GLY A 208 REMARK 465 SER A 209 REMARK 465 THR A 210 REMARK 465 THR A 211 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 32 -39.69 -38.66 REMARK 500 ILE A 63 -70.76 -65.94 REMARK 500 PRO A 87 140.02 -37.15 REMARK 500 ASP A 143 -122.76 45.83 REMARK 500 LYS A 206 -166.29 -119.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HLI A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1003 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DT6 RELATED DB: PDB DBREF 4DUM A 1 217 UNP P06730 IF4E_HUMAN 1 217 SEQADV 4DUM MET A -22 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASP A -21 UNP P06730 EXPRESSION TAG SEQADV 4DUM TYR A -20 UNP P06730 EXPRESSION TAG SEQADV 4DUM LYS A -19 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASP A -18 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASP A -17 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASP A -16 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASP A -15 UNP P06730 EXPRESSION TAG SEQADV 4DUM LYS A -14 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -13 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -12 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -11 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -10 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -9 UNP P06730 EXPRESSION TAG SEQADV 4DUM HIS A -8 UNP P06730 EXPRESSION TAG SEQADV 4DUM THR A -7 UNP P06730 EXPRESSION TAG SEQADV 4DUM GLU A -6 UNP P06730 EXPRESSION TAG SEQADV 4DUM ASN A -5 UNP P06730 EXPRESSION TAG SEQADV 4DUM LEU A -4 UNP P06730 EXPRESSION TAG SEQADV 4DUM TYR A -3 UNP P06730 EXPRESSION TAG SEQADV 4DUM PHE A -2 UNP P06730 EXPRESSION TAG SEQADV 4DUM GLN A -1 UNP P06730 EXPRESSION TAG SEQADV 4DUM GLY A 0 UNP P06730 EXPRESSION TAG SEQRES 1 A 240 MET ASP TYR LYS ASP ASP ASP ASP LYS HIS HIS HIS HIS SEQRES 2 A 240 HIS HIS THR GLU ASN LEU TYR PHE GLN GLY MET ALA THR SEQRES 3 A 240 VAL GLU PRO GLU THR THR PRO THR PRO ASN PRO PRO THR SEQRES 4 A 240 THR GLU GLU GLU LYS THR GLU SER ASN GLN GLU VAL ALA SEQRES 5 A 240 ASN PRO GLU HIS TYR ILE LYS HIS PRO LEU GLN ASN ARG SEQRES 6 A 240 TRP ALA LEU TRP PHE PHE LYS ASN ASP LYS SER LYS THR SEQRES 7 A 240 TRP GLN ALA ASN LEU ARG LEU ILE SER LYS PHE ASP THR SEQRES 8 A 240 VAL GLU ASP PHE TRP ALA LEU TYR ASN HIS ILE GLN LEU SEQRES 9 A 240 SER SER ASN LEU MET PRO GLY CYS ASP TYR SER LEU PHE SEQRES 10 A 240 LYS ASP GLY ILE GLU PRO MET TRP GLU ASP GLU LYS ASN SEQRES 11 A 240 LYS ARG GLY GLY ARG TRP LEU ILE THR LEU ASN LYS GLN SEQRES 12 A 240 GLN ARG ARG SER ASP LEU ASP ARG PHE TRP LEU GLU THR SEQRES 13 A 240 LEU LEU CYS LEU ILE GLY GLU SER PHE ASP ASP TYR SER SEQRES 14 A 240 ASP ASP VAL CYS GLY ALA VAL VAL ASN VAL ARG ALA LYS SEQRES 15 A 240 GLY ASP LYS ILE ALA ILE TRP THR THR GLU CYS GLU ASN SEQRES 16 A 240 ARG GLU ALA VAL THR HIS ILE GLY ARG VAL TYR LYS GLU SEQRES 17 A 240 ARG LEU GLY LEU PRO PRO LYS ILE VAL ILE GLY TYR GLN SEQRES 18 A 240 SER HIS ALA ASP THR ALA THR LYS SER GLY SER THR THR SEQRES 19 A 240 LYS ASN ARG PHE VAL VAL HET HLI A1001 32 HET EDO A1002 4 HET EDO A1003 4 HETNAM HLI (4-{7-[2-(4-CHLOROPHENOXY)ETHYL]-2-(METHYLAMINO)-6-OXO- HETNAM 2 HLI 6,7-DIHYDRO-1H-PURIN-8-YL}PHENYL)PHOSPHONIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 HLI C20 H19 CL N5 O5 P FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 HOH *14(H2 O) HELIX 1 1 ASN A 30 TYR A 34 5 5 HELIX 2 2 THR A 55 ASN A 59 1 5 HELIX 3 3 VAL A 69 ILE A 79 1 11 HELIX 4 4 LEU A 81 LEU A 85 5 5 HELIX 5 5 ASP A 104 ARG A 109 1 6 HELIX 6 6 GLN A 120 ASP A 125 1 6 HELIX 7 7 ASP A 125 GLY A 139 1 15 HELIX 8 8 PHE A 142 ASP A 147 5 6 HELIX 9 9 ASN A 172 GLY A 188 1 17 HELIX 10 10 HIS A 200 ALA A 204 1 5 SHEET 1 A 8 LEU A 60 THR A 68 0 SHEET 2 A 8 PRO A 38 PHE A 48 -1 N PHE A 47 O ARG A 61 SHEET 3 A 8 ASP A 90 LYS A 95 -1 O PHE A 94 N ALA A 44 SHEET 4 A 8 VAL A 149 ASN A 155 -1 O ALA A 152 N LEU A 93 SHEET 5 A 8 LYS A 162 THR A 167 -1 O LYS A 162 N ASN A 155 SHEET 6 A 8 GLY A 111 THR A 116 -1 N ILE A 115 O ILE A 163 SHEET 7 A 8 ILE A 195 SER A 199 -1 O GLY A 196 N LEU A 114 SHEET 8 A 8 PHE A 215 VAL A 217 -1 O PHE A 215 N TYR A 197 SITE 1 AC1 13 TRP A 56 LEU A 60 ASP A 90 SER A 92 SITE 2 AC1 13 PRO A 100 MET A 101 TRP A 102 GLU A 103 SITE 3 AC1 13 ARG A 157 LYS A 162 TRP A 166 ARG A 173 SITE 4 AC1 13 ARG A 181 SITE 1 AC2 1 TRP A 73 SITE 1 AC3 1 ASN A 77 CRYST1 38.225 58.766 125.442 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026161 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017017 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007972 0.00000